GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bedrocan Cannabis Corp (FRA:8BC) » Definitions » Cash Flow from Financing

Bedrocan Cannabis (FRA:8BC) Cash Flow from Financing : €1.89 Mil (TTM As of Apr. 2015)


View and export this data going back to . Start your Free Trial

What is Bedrocan Cannabis Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Apr. 2015, Bedrocan Cannabis paid €0.00 Mil more to buy back shares than it received from issuing new shares. It received €1.49 Mil from issuing more debt. It paid €0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received €0.00 Mil from paying cash dividends to shareholders. It received €0.40 Mil on other financial activities. In all, Bedrocan Cannabis earned €1.89 Mil on financial activities for the three months ended in Apr. 2015.


Bedrocan Cannabis Cash Flow from Financing Historical Data

The historical data trend for Bedrocan Cannabis's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bedrocan Cannabis Cash Flow from Financing Chart

Bedrocan Cannabis Annual Data
Trend Jan13 Jan14 Jan15
Cash Flow from Financing
- 0.18 -

Bedrocan Cannabis Quarterly Data
Jan13 Apr13 Jul13 Oct13 Jan14 Apr14 Jul14 Oct14 Jan15 Apr15
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.89

Bedrocan Cannabis Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Bedrocan Cannabis's Cash from Financing for the fiscal year that ended in Jan. 2015 is calculated as:

Bedrocan Cannabis's Cash from Financing for the quarter that ended in Apr. 2015 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.89 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bedrocan Cannabis  (FRA:8BC) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Bedrocan Cannabis's issuance of stock for the three months ended in Apr. 2015 was €0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Bedrocan Cannabis's repurchase of stock for the three months ended in Apr. 2015 was €0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Bedrocan Cannabis's net issuance of debt for the three months ended in Apr. 2015 was €1.49 Mil. Bedrocan Cannabis received €1.49 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Bedrocan Cannabis's net issuance of preferred for the three months ended in Apr. 2015 was €0.00 Mil. Bedrocan Cannabis paid €0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Bedrocan Cannabis's cash flow for dividends for the three months ended in Apr. 2015 was €0.00 Mil. Bedrocan Cannabis received €0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Bedrocan Cannabis's other financing for the three months ended in Apr. 2015 was €0.40 Mil. Bedrocan Cannabis received €0.40 Mil on other financial activities.


Bedrocan Cannabis Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Bedrocan Cannabis's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Bedrocan Cannabis (FRA:8BC) Business Description

Traded in Other Exchanges
N/A
Address
POCML 2 Inc is a capital pool company. The Company will not carry on any business other than the identification and evaluation of assets or businesses with a view to completing a proposed Qualifying Transaction.

Bedrocan Cannabis (FRA:8BC) Headlines

No Headlines